|
US6635632B1
(en)
|
1996-12-23 |
2003-10-21 |
Athena Neurosciences, Inc. |
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
US6552013B1
(en)
|
1998-06-22 |
2003-04-22 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
JP2002518481A
(ja)
*
|
1998-06-22 |
2002-06-25 |
エラン ファーマシューティカルズ，インコーポレイテッド |
β−アミロイドペプチドの放出および／またはその合成を阻害するための化合物
|
|
US6509331B1
(en)
|
1998-06-22 |
2003-01-21 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
CA2324475A1
(en)
*
|
1998-06-22 |
1999-12-29 |
Elan Pharmaceuticals, Inc. |
Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
|
|
US6774125B2
(en)
|
1998-06-22 |
2004-08-10 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
AU5204799A
(en)
*
|
1998-06-22 |
2000-01-10 |
Elan Pharmaceuticals, Inc. |
Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
|
|
US6958330B1
(en)
|
1998-06-22 |
2005-10-25 |
Elan Pharmaceuticals, Inc. |
Polycyclic α-amino-ε-caprolactams and related compounds
|
|
NZ525513A
(en)
|
1998-08-07 |
2004-09-24 |
Pont Pharmaceuticals Du |
Succinoylamino lactams as inhibitors of Abeta protein production
|
|
HRP990246A2
(en)
|
1998-08-07 |
2000-06-30 |
Du Pont Pharm Co |
Succinoylamino benzodiazepines as inhibitors of a beta protein production
|
|
EP1131634A2
(en)
|
1998-09-30 |
2001-09-12 |
Elan Pharmaceuticals, Inc. |
Determining the mechanism of beta-amyloid peptide generation
|
|
WO2000038618A2
(en)
|
1998-12-24 |
2000-07-06 |
Du Pont Pharmaceuticals Company |
SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
|
|
ATE455106T1
(de)
|
1999-01-22 |
2010-01-15 |
Elan Pharm Inc |
Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
|
|
US6503902B2
(en)
|
1999-09-13 |
2003-01-07 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production
|
|
US6960576B2
(en)
|
1999-09-13 |
2005-11-01 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
|
|
EP1222176A1
(en)
|
1999-10-08 |
2002-07-17 |
Bristol-Myers Squibb Pharma Company |
AMINO LACTAM SULFONAMIDES AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION
|
|
EP1251837A2
(en)
|
1999-12-23 |
2002-10-30 |
Neurochem, Inc. |
Compounds and methods for modulating cerebral amyloid angiopathy
|
|
CA2395862A1
(en)
|
2000-02-17 |
2001-08-23 |
Hong Liu |
Succinoylamino carbocycles and heterocycles as inhibitors of a.beta. protein production
|
|
CN1436175A
(zh)
|
2000-04-03 |
2003-08-13 |
布里斯托尔-迈尔斯斯奎布药品公司 |
作为Aβ－蛋白生产抑制剂的环状内酰胺
|
|
EP1268434A1
(en)
|
2000-04-03 |
2003-01-02 |
Bristol-Myers Squibb Pharma Company |
Cyclic lactams as inhibitors of a-beta protein production
|
|
WO2001077086A1
(en)
|
2000-04-11 |
2001-10-18 |
Dupont Pharmaceuticals Company |
SUBSTITUTED LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION
|
|
US6878363B2
(en)
|
2000-05-17 |
2005-04-12 |
Bristol-Myers Squibb Pharma Company |
Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
|
|
CN1386118A
(zh)
|
2000-06-01 |
2002-12-18 |
布里斯托尔-迈尔斯斯奎布药品公司 |
作为Aβ蛋白产生抑制剂的被环状琥珀酸酯取代的内酰胺类化合物
|
|
US6432944B1
(en)
|
2000-07-06 |
2002-08-13 |
Bristol-Myers Squibb Company |
Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
|
|
JP4212358B2
(ja)
*
|
2000-12-28 |
2009-01-21 |
第一三共株式会社 |
Ｖｌａ−４阻害薬
|
|
CN100396680C
(zh)
*
|
2000-12-28 |
2008-06-25 |
第一制药株式会社 |
极迟抗原-4抑制剂
|
|
BR0214731A
(pt)
*
|
2001-12-04 |
2004-12-07 |
Elan Pharm Inc |
Métodos de tratar ou prevenir mal de alzheimer em um indivìduo e uma doença evidenciada por depósitos beta-amilóides sobre ou dentro do cérebro, de tratar um indivìduo que possui, ou para prevenir que um indivìduo adquira, uma doença ou condição, de inibir atividade de beta-secretase, clivagem de um isótipo de protéina precursora de amilóide e produção de peptìdeo beta amilóide e de placa amilóde de um animal e de produzir um complexo de beta-secretase, uso de um composto e composição
|
|
TWI281470B
(en)
|
2002-05-24 |
2007-05-21 |
Elan Pharm Inc |
Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
|
|
TW200307671A
(en)
|
2002-05-24 |
2003-12-16 |
Elan Pharm Inc |
Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
|
|
US7459476B2
(en)
|
2002-06-27 |
2008-12-02 |
Elan Pharmaceuticals, Inc. |
Methods for treating Alzheimer's disease using hydroxyethylene compounds containing a heterocyclic amide bond isostere
|
|
FR2842523A1
(fr)
*
|
2002-07-17 |
2004-01-23 |
Sanofi Synthelabo |
Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
|
|
CA2528586A1
(en)
|
2003-07-24 |
2005-02-03 |
Daiichi Pharmaceutical Co., Ltd. |
Cyclohexanecarboxylic acid compound
|
|
CA2624524C
(en)
|
2005-09-29 |
2014-07-08 |
Elan Pharmaceuticals, Inc. |
Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
BRPI0616687A2
(pt)
|
2005-09-29 |
2011-06-28 |
Elan Pharm Inc |
compostos de pirimidinil amida que inibem a adesão leucocitária mediada por vla-4
|
|
CA2643838A1
(en)
|
2006-02-27 |
2007-09-07 |
Elan Pharmaceuticals, Inc. |
Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
|